EP Patent

EP2968198B1 — Stable transdermal amphetamine compositions and methods of manufacture

Assigned to Noven Pharmaceuticals Inc · Expires 2018-11-21 · 7y expired

What this patent protects

Patent listed against dextroamphetamine.

Drugs covered by this patent

dextroamphetamine (DEXTROAMPHETAMINE)

Patent Metadata

Patent number: EP2968198B1
Jurisdiction: EP
Classification: —
Expires: 2018-11-21
Drug substance claim: No
Drug product claim: No
Assignee: Noven Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.